US5618922AExpiredUtility

NM03 antibody materials and methods

Assignee: NISSIN FOOD PRODUCTS LTDPriority: Jul 25, 1994Filed: Jul 25, 1994Granted: Apr 8, 1997

Est. expiryJul 25, 2014(expired)· nominal 20-yr term from priority

Inventors:Tsuneya Ohno Masaki Terada Yukio Yoneda

C07K 16/1145C07K 2317/34A61K 38/00

PatentIndex Score

Cited by

References

Claims

Abstract

The present invention provides a monoclonal antibody, designated NM03, which specifically binds HIV-1 gp 120.

Claims

exact text as granted — not AI-modified

We claim: 
     
       1. A monoclonal antibody characterized by the ability to specifically bind to a sequence of amino acids of HIV-1 gp120 or gp160 protein consisting of the sequence set out in SEQ ID NO:1 and the ability to neutralize, in vitro, the infection of H9 cells by live HIV-1 strain MN in p24 assays. 
     
     
       2. The monoclonal antibody according to claim 1 further characterized by being an IgM antibody. 
     
     
       3. A hybridoma cell line which secretes a monoclonal antibody according to claim 1 or 2. 
     
     
       4. The hybridoma cell line having ATCC Accession No. HB 11614. 
     
     
       5. The monoclonal antibody, NM03, produced by the hybridoma cell line of claim 4.

Join the waitlist — get patent alerts

Track US5618922A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.